Update on serologic testing in COVID-19.

Area of Science:

• Immunology
• Infectious Diseases
• Diagnostic Medicine

Background:

• Serologic tests are diagnostic tools for COVID-19, with emerging evidence supporting their role in clinical management.
• Challenges exist due to limited commercial test availability and a lack of robust trials validating sensitivity and specificity.
• Precise determination of the clinical application of serologic testing is necessary.

Purpose of the Study:

• To discuss the clinical utility of anti-SARS-CoV-2 serology testing.
• To propose diagnostic algorithms incorporating serological tests for COVID-19 patients.
• To address the need for precise clinical application guidelines.

Main Methods:

• Literature review on the role of serologic tests in COVID-19.
• Analysis of diagnostic challenges, including test availability and validation.
• Development of proposed diagnostic algorithms for integrating serology.

Main Results:

• Serologic testing offers valuable insights for COVID-19 diagnosis and patient management.
• Diagnostic algorithms can enhance the clinical utility of serology when validated.
• Further research is needed to establish definitive test performance metrics.

Conclusions:

• Anti-SARS-CoV-2 serology testing has a defined role in the clinical setting.
• Diagnostic algorithms can optimize the use of serologic tests in COVID-19 management.
• Addressing limitations in test availability and validation is crucial for widespread clinical adoption.